SG11202105650RA - Pharmaceutical composition, comprising inhibitory peptide against fas signaling, for prevention or treatment of obesity, fatty liver, or steatohepatitis - Google Patents
Pharmaceutical composition, comprising inhibitory peptide against fas signaling, for prevention or treatment of obesity, fatty liver, or steatohepatitisInfo
- Publication number
- SG11202105650RA SG11202105650RA SG11202105650RA SG11202105650RA SG11202105650RA SG 11202105650R A SG11202105650R A SG 11202105650RA SG 11202105650R A SG11202105650R A SG 11202105650RA SG 11202105650R A SG11202105650R A SG 11202105650RA SG 11202105650R A SG11202105650R A SG 11202105650RA
- Authority
- SG
- Singapore
- Prior art keywords
- steatohepatitis
- obesity
- prevention
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180154274 | 2018-12-04 | ||
| PCT/KR2019/015585 WO2020116810A1 (en) | 2018-12-04 | 2019-11-14 | Pharmaceutical composition, comprising inhibitory peptide against fas signaling, for prevention or treatment of obesity, fatty liver, or steatohepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105650RA true SG11202105650RA (en) | 2021-06-29 |
Family
ID=70974360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105650RA SG11202105650RA (en) | 2018-12-04 | 2019-11-14 | Pharmaceutical composition, comprising inhibitory peptide against fas signaling, for prevention or treatment of obesity, fatty liver, or steatohepatitis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220088115A1 (en) |
| EP (1) | EP3892289A4 (en) |
| JP (1) | JP2022514125A (en) |
| KR (2) | KR102173183B1 (en) |
| CN (1) | CN113164549A (en) |
| AU (1) | AU2019392040A1 (en) |
| BR (1) | BR112021010865A2 (en) |
| CA (1) | CA3121901A1 (en) |
| MX (1) | MX2021006605A (en) |
| SG (1) | SG11202105650RA (en) |
| WO (1) | WO2020116810A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022086039A1 (en) * | 2020-10-19 | 2022-04-28 | 주식회사 시그넷바이오텍 | Composition for preventing or treating macular degeneration comprising peptide for inhibiting fas signaling |
| KR20230057747A (en) * | 2021-10-22 | 2023-05-02 | 한양대학교 산학협력단 | Composition for preventing or treating ischemic stroke comprising Fas-blocking peptide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2490542C (en) * | 2002-05-23 | 2013-07-16 | Mark I. Greene | Fas peptide mimetics and uses thereof |
| WO2009089362A1 (en) * | 2008-01-08 | 2009-07-16 | The Trustees Of The University Of Pennsylvania | Methods of treatment using agents for regulating fas receptor function in skin and hair related pathologies |
| KR101646726B1 (en) * | 2013-08-12 | 2016-08-09 | 한양대학교 산학협력단 | Cyclized poly Fas Targeting Peptides and Uses Thereof |
| EP3375450B1 (en) * | 2015-11-13 | 2023-06-28 | Industry - University Cooperation Foundation Hanyang University | Composition for preventing or treating an ischemic cerebrovascular disease through nasal administration |
-
2019
- 2019-11-14 SG SG11202105650RA patent/SG11202105650RA/en unknown
- 2019-11-14 WO PCT/KR2019/015585 patent/WO2020116810A1/en unknown
- 2019-11-14 BR BR112021010865A patent/BR112021010865A2/en not_active IP Right Cessation
- 2019-11-14 MX MX2021006605A patent/MX2021006605A/en unknown
- 2019-11-14 US US17/299,945 patent/US20220088115A1/en active Pending
- 2019-11-14 AU AU2019392040A patent/AU2019392040A1/en not_active Abandoned
- 2019-11-14 EP EP19892572.9A patent/EP3892289A4/en not_active Withdrawn
- 2019-11-14 CN CN201980080751.XA patent/CN113164549A/en active Pending
- 2019-11-14 JP JP2021553754A patent/JP2022514125A/en not_active Withdrawn
- 2019-11-14 CA CA3121901A patent/CA3121901A1/en not_active Abandoned
- 2019-11-14 KR KR1020190146085A patent/KR102173183B1/en active IP Right Grant
-
2020
- 2020-07-30 KR KR1020200095170A patent/KR20200096449A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP3892289A1 (en) | 2021-10-13 |
| KR20200067745A (en) | 2020-06-12 |
| KR102173183B1 (en) | 2020-11-03 |
| KR20200096449A (en) | 2020-08-12 |
| EP3892289A4 (en) | 2022-09-14 |
| US20220088115A1 (en) | 2022-03-24 |
| JP2022514125A (en) | 2022-02-09 |
| CN113164549A (en) | 2021-07-23 |
| MX2021006605A (en) | 2021-07-07 |
| WO2020116810A1 (en) | 2020-06-11 |
| AU2019392040A1 (en) | 2021-06-17 |
| CA3121901A1 (en) | 2020-06-11 |
| BR112021010865A2 (en) | 2021-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004025B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| EP3777888A4 (en) | Pharmaceutical composition for treatment and/or prevention of cancer | |
| IL275188A (en) | Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis | |
| EP3685838A4 (en) | Compound for treatment or prevention of obesity or diseases related to obesity, and application thereof | |
| EP3189849A4 (en) | Novel peptide for inhibiting fat accumulation, and pharmaceutical composition for preventing or treating obesity, comprising same | |
| SG11202105650RA (en) | Pharmaceutical composition, comprising inhibitory peptide against fas signaling, for prevention or treatment of obesity, fatty liver, or steatohepatitis | |
| EP3777848A4 (en) | Composition for prevention or treatment of stoke | |
| IL284029A (en) | Peptides for treatment and prevention of diabetes and associated disorders | |
| IL257336B (en) | Compounds and pharmaceutical compositions for prevention or treatment of parasitic diseases | |
| SG11202106163RA (en) | Pharmaceutical composition for prevention or treatment of cancer comprising lactobacillus sakei wikim30 as active ingredient | |
| EP3777847A4 (en) | Pharmaceutical composition for prevention or treatment of fibrosis | |
| EP3632447A4 (en) | Pharmaceutical composition for prevention or treatment of bone-related disease | |
| EP3838272A4 (en) | Composition for prevention or treatment of neurodegenerative disease | |
| SI3758799T1 (en) | Composition for the prevention and treatment of skin damages caused by photo-exposure | |
| KR102316727B9 (en) | Pharmaceutical composition for preventing or treating atopic diseases | |
| EP3811958A4 (en) | Composition for the prevention and/or treatment of haemorrhoids | |
| SI3586832T1 (en) | Pharmaceutical composition for the treatment of constipation | |
| GB201718927D0 (en) | Pharmaceutical composition suitable for intestinal cancer treatment and/or prevention | |
| GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| ZA202201449B (en) | Veterinary compositions for the prevention and/or treatment of cryptosporidiosis | |
| IL287046A (en) | Solid pharmaceutical compositions for treating hcv | |
| EP3708574A4 (en) | Peptide for inhibiting skin inflammation and composition containing same for prevention or treatment of skin inflammation | |
| GB201718925D0 (en) | Pharmaceutical composition suitable for gastric cancer treatment and/or prevention | |
| GB201817343D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| GB201809836D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |